Zacks Investment Research upgraded shares of RTI SURGICAL (RTIX) from UNDERPERFORM to NEUTRAL on December 31, 2013, with a target price of $3.50.
RTI Surgical Inc. is a surgical implant company. Its implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures. RTI Surgical Inc., formerly known as RTI Biologics, Inc., is headquartered in Alachua, Fla.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on RTI SURGICAL (RTIX),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment